Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297
Monoclonal antibodies are crucial recombinant biopharmaceuticals, with N-glycosylation at Asn297 essential for their functionality. Plants are increasingly used for antibody production, achieving high expression levels and enabling glycoengineering to produce homogenous human-like N-glycan structure...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Plant Science |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpls.2024.1531710/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591684077092864 |
|---|---|
| author | Kathrin Göritzer Valentina Ruocco Ulrike Vavra Shiva Izadi Omayra C. Bolaños-Martínez Thareeya Phetphoung Nuttapat Pisuttinusart Waranyoo Phoolcharoen Richard Strasser |
| author_facet | Kathrin Göritzer Valentina Ruocco Ulrike Vavra Shiva Izadi Omayra C. Bolaños-Martínez Thareeya Phetphoung Nuttapat Pisuttinusart Waranyoo Phoolcharoen Richard Strasser |
| author_sort | Kathrin Göritzer |
| collection | DOAJ |
| description | Monoclonal antibodies are crucial recombinant biopharmaceuticals, with N-glycosylation at Asn297 essential for their functionality. Plants are increasingly used for antibody production, achieving high expression levels and enabling glycoengineering to produce homogenous human-like N-glycan structures. However, plant-produced human IgG1 often shows significant underglycosylation with potential adverse effects for immune functions and stability. This study addressed this limitation of the widely used plant-based expression platform Nicotiana benthamiana by employing protein engineering to enhance N-glycosylation occupancy in plant-produced IgG1. This was achieved through an amino acid mutation near the conserved glycosylation site in the CH2 domain of the heavy chain. The transient expression of trastuzumab and SARS-CoV-2 neutralizing IgG1 antibody COVA2-15 in N. benthamiana, with mutations such as Y300L, resulted in a notable improvement in glycosylation occupancy. While the structural integrity and monodispersity of the IgG1 variant remained unaltered, an improvement in thermal stability was observed. Furthermore, functional assays showed that antigen binding and human hFcRn interaction were unaffected, while FcγRIIIa binding affinity increased. These findings demonstrate the potential of protein-engineering to enhance the quality and functionality of plant-produced IgG1 antibodies, making them comparable to mammalian-produced counterparts. |
| format | Article |
| id | doaj-art-277997752aba4e17aa40d2806304a4a7 |
| institution | Kabale University |
| issn | 1664-462X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Plant Science |
| spelling | doaj-art-277997752aba4e17aa40d2806304a4a72025-01-22T07:11:27ZengFrontiers Media S.A.Frontiers in Plant Science1664-462X2025-01-011510.3389/fpls.2024.15317101531710Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297Kathrin Göritzer0Valentina Ruocco1Ulrike Vavra2Shiva Izadi3Omayra C. Bolaños-Martínez4Thareeya Phetphoung5Nuttapat Pisuttinusart6Waranyoo Phoolcharoen7Richard Strasser8Department of Applied Genetics and Cell Biology, BOKU University, Vienna, AustriaDepartment of Applied Genetics and Cell Biology, BOKU University, Vienna, AustriaDepartment of Applied Genetics and Cell Biology, BOKU University, Vienna, AustriaDepartment of Applied Genetics and Cell Biology, BOKU University, Vienna, AustriaDepartment of Applied Genetics and Cell Biology, BOKU University, Vienna, AustriaDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, ThailandDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, ThailandDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, ThailandDepartment of Applied Genetics and Cell Biology, BOKU University, Vienna, AustriaMonoclonal antibodies are crucial recombinant biopharmaceuticals, with N-glycosylation at Asn297 essential for their functionality. Plants are increasingly used for antibody production, achieving high expression levels and enabling glycoengineering to produce homogenous human-like N-glycan structures. However, plant-produced human IgG1 often shows significant underglycosylation with potential adverse effects for immune functions and stability. This study addressed this limitation of the widely used plant-based expression platform Nicotiana benthamiana by employing protein engineering to enhance N-glycosylation occupancy in plant-produced IgG1. This was achieved through an amino acid mutation near the conserved glycosylation site in the CH2 domain of the heavy chain. The transient expression of trastuzumab and SARS-CoV-2 neutralizing IgG1 antibody COVA2-15 in N. benthamiana, with mutations such as Y300L, resulted in a notable improvement in glycosylation occupancy. While the structural integrity and monodispersity of the IgG1 variant remained unaltered, an improvement in thermal stability was observed. Furthermore, functional assays showed that antigen binding and human hFcRn interaction were unaffected, while FcγRIIIa binding affinity increased. These findings demonstrate the potential of protein-engineering to enhance the quality and functionality of plant-produced IgG1 antibodies, making them comparable to mammalian-produced counterparts.https://www.frontiersin.org/articles/10.3389/fpls.2024.1531710/fullmonoclonal antibodiesNicotiana benthamianaIgG1N-glycosylationglycosylation efficiency |
| spellingShingle | Kathrin Göritzer Valentina Ruocco Ulrike Vavra Shiva Izadi Omayra C. Bolaños-Martínez Thareeya Phetphoung Nuttapat Pisuttinusart Waranyoo Phoolcharoen Richard Strasser Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297 Frontiers in Plant Science monoclonal antibodies Nicotiana benthamiana IgG1 N-glycosylation glycosylation efficiency |
| title | Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297 |
| title_full | Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297 |
| title_fullStr | Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297 |
| title_full_unstemmed | Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297 |
| title_short | Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297 |
| title_sort | improving the n glycosylation occupancy of plant produced igg1 by engineering the amino acid environment at asn297 |
| topic | monoclonal antibodies Nicotiana benthamiana IgG1 N-glycosylation glycosylation efficiency |
| url | https://www.frontiersin.org/articles/10.3389/fpls.2024.1531710/full |
| work_keys_str_mv | AT kathringoritzer improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 AT valentinaruocco improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 AT ulrikevavra improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 AT shivaizadi improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 AT omayracbolanosmartinez improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 AT thareeyaphetphoung improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 AT nuttapatpisuttinusart improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 AT waranyoophoolcharoen improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 AT richardstrasser improvingthenglycosylationoccupancyofplantproducedigg1byengineeringtheaminoacidenvironmentatasn297 |